Girard Gibbs Appointed Lead Counsel for Topical Steroids Antitrust Litigation

On December 27, 2016, Girard Gibbs LLP was selected as interim-lead counsel in litigation alleging that manufacturers of topical steroids had conspired to fix drug prices. A total of six drug makers who produce generic versions of clobetasol, desonide, and fluocinonide have been suspected of involvement. Judge William Pauley of the Southern District of New York appointed Girard Gibbs for its experience with other litigation involving the anticompetitive practices of pharmaceutical companies. To read more, click here.